<DOC>
	<DOCNO>NCT01638104</DOCNO>
	<brief_summary>The purpose study investigate safety tolerability ANX-042 administer continuous intravenous ( IV ) infusion healthy volunteer .</brief_summary>
	<brief_title>ANX-042 Healthy Volunteer Dose Escalation Study</brief_title>
	<detailed_description>Each participant receive total two , approximately 12-hour continuous infusion ANX-042 one 12-hour continuous infusion placebo , 36-hour washout period treatment .</detailed_description>
	<criteria>Men woman nonreproductive potential ( WNRP ) Men must willing use effective contraception donate sperm 90 day final dose study drug Women must nonreproductive potential defined history surgical sterilization postmenopausal status ( , great ( &gt; ) 50 year age &gt; 12 month amenorrhea use hormonal contraceptive &gt; 50 year age 612 month amenorrhea follicle stimulate hormone ( FSH ) level &gt; 40 international unit/liter ( IU/L ) Good health status , physically active without cardiorespiratory limitation minimal concomitant medication determine medical history physical examination Able willing comply study procedure , include control sodium ( Na ) intake restriction caffeine tobacco product Have give write informed consent prior initiation study procedure History cardiovascular disease , unexplained syncope , postural tachycardia syndrome frequent postural hypotension History current evidence respiratory , hepatic , renal , gastrointestinal , endocrine , hematological neurological disorder would constitute risk take study medication interfere interpretation data Clinically significantly abnormal clinical laboratory result ( include Hepatitis B , Hepatitis C Human Immunodeficiency Virus ( HIV ) serology ) physical examination result ( confirmed repeat measurement , appropriate ) , opinion Investigator , would constitute risk take study medication interfere interpretation data Abnormal orthostatic Blood Pressure/Heart Rate ( BP/HR ) response screen define : Systolic Blood Pressure ( BP ) decrease &gt; 20 millimeter mercury ( mmHg ) Diastolic BP decrease &gt; 10 mmHg , HR increase &gt; 25 beat per minute ( bpm ) level 100 bpm One two supine value must obtain 8 10 minute supine rest . One two upright value must obtain 3 5 minute upright arm passively support maintain brachial artery heart level Abnormal 12lead electrocardiogram ( ECG ) interfere proper measurement QTinterval , opinion Investigator , increase risk participate study Elevated BP ( &gt; 140/90 mmHg ) posture , confirm repeat measurement Current use ( within 7 day first dose ) expect need concomitant medication hemodynamic effect include : nonsteroidal antiinflammatory drug ( NSAIDS ) , decongestant , BP medication , diuretic , monoamine oxidase inhibitor , norepinephrine uptake inhibitor ( example , attentiondeficit disorder medication , antidepressant ) erectile dysfunction medication . Medications low likelihood hemodynamic renal effect permit ( example , acetaminophen , vitamin , stable thyroid hormone , gastritis therapy , antihistamine , topical medication , et cetera ) approval Investigator Evidence current recent use know drug abuse and/or positive finding urinary drug screen History average weekly alcohol intake exceed 21 unit per week ( 1 unit equal ( = ) 12 ounce ( oz ) 360 milliliter ( mL ) beer ; 5 oz 150 mL wine ; 1.5 oz 45 mL distilled spirit ) , unwilling stop alcohol consumption duration study History regular smoking &gt; 5 cigarette , cigar and/or pipe bowl tobacco per day Known allergy nesiritide ( Natrecor ) History blood donation &gt; 500 mL within one month , plasma donation within 14 day , first dosing Are currently enrol , complete discontinue within last 30 day , clinical trial involve investigational product concurrently enrol type medical research judge scientifically medically compatible study Are investigator site personnel directly affiliate study immediate family member . Immediate family define spouse , parent , child sibling , whether biological legally adopt Are Lilly Anexon employee employee thirdparty organization ( TPO ) involve study require exclusion employee</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>